
Severe hypertriglyceridemia is an uncommon but serious complication of diabetic ketoacidosis in children and may be associated with acute pancreatitis. We report the case of an 8‐year‐old girl with no prior medical history who presented with polyuria, polydipsia, and headache and was found to have moderate diabetic ketoacidosis with metabolic acidosis and ketonuria. The blood sample appeared milky, and laboratory testing revealed extreme hypertriglyceridemia with triglyceride levels exceeding 36.6 mmol/L, despite the absence of abdominal pain at presentation. A diagnosis of acute pancreatitis was established on an elevated serum lipase (700 IU/L) and corroborative findings from an abdominal computed tomography scan. Further investigations showed a markedly elevated glycated hemoglobin level, indicating prolonged hyperglycemia. Based on the clinical presentation, a diagnosis of Type 1 diabetes mellitus was made, although C‐peptide and autoantibodies were not available. The patient was managed conservatively with intravenous insulin infusion, fluid resuscitation, electrolyte correction, and supportive care, with adjunctive enoxaparin leading to a gradual decline in triglyceride levels without the need for therapeutic plasma exchange (TPE). Clinical and biological outcomes were favorable. This case emphasizes the importance of early recognition of hypertriglyceridemia and pancreatitis in pediatric diabetic ketoacidosis, even in the absence of abdominal symptoms. Furthermore, in this hemodynamically stable child, insulin‐based conservative management with supportive care was sufficient to avoid TPE. Because enoxaparin was given concomitantly, its independent contribution cannot be determined from a single case.
Mevalonate kinase deficiency (MKD) is a rare autosomal recessive autoinflammatory disorder caused by biallelic pathogenic variants in the mevalonate kinase ( MVK ) gene and typically presents during infancy. Its gastrointestinal and perianal manifestations may closely mimic very‐early‐onset inflammatory bowel disease (VEO‐IBD), potentially leading to delayed or incorrect diagnosis. We report a 2‐year‐old boy with recurrent febrile inflammatory episodes beginning in early infancy, persistent perianal fistulas, recurrent skin lesions, splenomegaly, elevated inflammatory markers, and severe recurrent anemia requiring repeated blood transfusions. VEO‐IBD, particularly isolated perianal Crohn disease, was initially suspected. However, colonoscopy demonstrated normal mucosa, histopathological examination of biopsies from multiple gastrointestinal segments revealed no features of chronic intestinal inflammation, and fecal calprotectin was negative. The combination of recurrent systemic inflammatory flares, facial rash, splenomegaly, severe perianal disease, absence of evidence of infection, and lack of objective luminal intestinal inflammation prompted genetic evaluation. Whole genome sequencing identified compound heterozygous pathogenic variants in the MVK gene, c.803T > C (p.Ile268Thr) and c.976G > A (p.Gly326Arg), confirming the diagnosis of MKD. This case highlights the importance of considering autoinflammatory diseases in infants and young children presenting with a VEO‐IBD‐like phenotype, particularly when recurrent systemic inflammation and severe perianal disease occur in the absence of objective evidence of luminal intestinal inflammation. Early recognition and genetic testing may facilitate timely diagnosis and appropriate management.
Hypotension following traumatic carotid artery dissection is rare, with most reported cases in the literature accompanied by bradycardia. We present a unique case of a 34‐year‐old man who sustained a unilateral traumatic carotid artery dissection following an automobile accident and presented with persistent hypotension but no bradycardia. Initial imaging revealed a hyperacute infarct in the right middle cerebral artery territory. The patient was successfully managed with vasopressors, including noradrenaline and midodrine, leading to blood pressure stabilization and eventual recovery. This case highlights the rare occurrence of hypotension without bradycardia after traumatic carotid artery dissection and demonstrates that conservative management with vasopressors can be effective in resource‐constrained settings where surgical intervention is limited.
Strongyloides stercoralis is an intestinal parasite endemic in tropical and subtropical regions. Most infections present with nonspecific manifestations, often leading to delayed diagnosis. We report the case of a previously healthy 51‐year‐old male who was admitted with persistent abdominal pain and chronic diarrhea, which later complicated into a partial bowel obstruction. Colonoscopy revealed scattered ulcerative lesions with pseudopolyp formation. Stool examination identified Strongyloides stercoralis rhabditiform larvae, and serological testing confirmed the diagnosis. He was successfully treated with a 7‐day course of oral ivermectin and supportive therapy, resulting in marked clinical improvement. Strongyloides stercoralis infection can cause severe colitis with intestinal obstruction and pseudopolyp formation even in immunocompetent individuals. Strongyloidiasis should be considered in patients with colitis of unknown etiology, particularly in endemic areas, to enable timely treatment and prevent life‐threatening complications.
Oral lichenoid drug reactions (OLDRs) are uncommon adverse reactions associated with various medications, including monoclonal antibodies. Romosozumab, a humanized monoclonal antibody targeting sclerostin, has emerged as an effective treatment for osteoporosis due to its dual action of increasing bone formation and reducing bone resorption. However, its safety profile continues to be explored. This case report describes a rare instance of OLDRs associated with romosozumab therapy in a postmenopausal patient undergoing treatment for osteoporosis. The patient presented with symptomatic oral mucosal lesions characterized by white reticular striae, erythematous patches, and ulcerations, clinically and histologically consistent with OLDRs. The temporal association between the initiation of romosozumab therapy and lesion onset, together with complete remission following completion of the planned 12-month treatment course, supports a probable association. This case highlights the importance of recognizing OLDRs as a potential adverse effect of romosozumab and underscores the need for clinicians to perform thorough oral examinations in patients reporting mucosal discomfort during treatment. Further research is necessary to elucidate the underlying mechanisms and incidence of this adverse reaction.